Latest News

Patient-reported satisfaction was higher in patients with breast cancer treated with olanzapine vs those who underwent treatment with placebo.
Olanzapine Combo Reduces Chemo-Induced Nausea, Vomiting in Breast Cancer

July 8th 2025

Survival benefit was observed in heavily pretreated populations, including those who progressed after checkpoint inhibition and antibody drug conjugates.
Bria-IMT Yields Updated Survival Benefit in Metastatic Breast Cancer

July 8th 2025

Phase 3 data affirm the use of partial-breast intensity-modulated radiotherapy as a standard of care in patients with low-risk early-stage breast cancer.
Partial-Breast Radiation Appears Effective, Safe in Early Breast Cancer

July 7th 2025

More News